- Home
- NNOX vs IMRX Comparison
NNOX vs IMRX Comparison
Compare NNOX & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- IMRX
- Stock Information
- Founded
- NNOX 2011
- IMRX 2008
- Country
- NNOX Israel
- IMRX United States
- Employees
- NNOX N/A
- IMRX N/A
- Industry
- NNOX Medical Electronics
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- NNOX Health Care
- IMRX Health Care
- Exchange
- NNOX Nasdaq
- IMRX Nasdaq
- Market Cap
- NNOX 253.8M
- IMRX 232.9M
- IPO Year
- NNOX 2020
- IMRX 2021
- Fundamental
- Price
- NNOX $3.88
- IMRX $6.48
- Analyst Decision
- NNOX Strong Buy
- IMRX Strong Buy
- Analyst Count
- NNOX 2
- IMRX 4
- Target Price
- NNOX $8.50
- IMRX $17.75
- AVG Volume (30 Days)
- NNOX 1.3M
- IMRX 1.7M
- Earning Date
- NNOX 11-20-2025
- IMRX 11-12-2025
- Dividend Yield
- NNOX N/A
- IMRX N/A
- EPS Growth
- NNOX N/A
- IMRX N/A
- EPS
- NNOX N/A
- IMRX N/A
- Revenue
- NNOX $11,886,000.00
- IMRX N/A
- Revenue This Year
- NNOX $20.50
- IMRX N/A
- Revenue Next Year
- NNOX $64.10
- IMRX N/A
- P/E Ratio
- NNOX N/A
- IMRX N/A
- Revenue Growth
- NNOX 17.36
- IMRX N/A
- 52 Week Low
- NNOX $3.60
- IMRX $1.10
- 52 Week High
- NNOX $11.00
- IMRX $10.08
- Technical
- Relative Strength Index (RSI)
- NNOX 45.89
- IMRX 54.65
- Support Level
- NNOX $3.87
- IMRX $5.23
- Resistance Level
- NNOX $4.17
- IMRX $5.92
- Average True Range (ATR)
- NNOX 0.21
- IMRX 0.43
- MACD
- NNOX -0.02
- IMRX 0.05
- Stochastic Oscillator
- NNOX 10.77
- IMRX 96.25
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.